Vir Biotechnology, Inc. (VIR)
11.70
+0.58
(+5.22%)
USD |
NASDAQ |
Oct 09, 16:00
11.49
-0.21
(-1.79%)
After-Hours: 04:57
Vir Biotechnology EPS Diluted (Quarterly) : 0.4742 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.4742 |
| March 31, 2026 | -0.853 |
| December 31, 2025 | -0.3083 |
| September 30, 2025 | -1.174 |
| June 30, 2025 | -0.8014 |
| March 31, 2025 | -0.8799 |
| December 31, 2024 | -0.7645 |
| September 30, 2024 | -1.564 |
| June 30, 2024 | -1.016 |
| March 31, 2024 | -0.4825 |
| December 31, 2023 | -0.8616 |
| September 30, 2023 | -1.217 |
| June 30, 2023 | -1.453 |
| March 31, 2023 | -1.055 |
| December 31, 2022 | -0.763 |
| September 30, 2022 | 1.299 |
| Date | Value |
|---|---|
| June 30, 2022 | -0.5775 |
| March 31, 2022 | 3.855 |
| December 31, 2021 | 3.923 |
| September 30, 2021 | 0.825 |
| June 30, 2021 | 0.462 |
| March 31, 2021 | -1.322 |
| December 31, 2020 | -0.83 |
| September 30, 2020 | -0.6725 |
| June 30, 2020 | -0.2711 |
| March 31, 2020 | -0.7126 |
| December 31, 2019 | -0.5924 |
| September 30, 2019 | -0.4405 |
| June 30, 2019 | -0.3093 |
| March 31, 2019 | -0.2614 |
| December 31, 2018 | -0.2406 |
| September 30, 2018 | -0.305 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Moderna, Inc. | -1.965 |
| Vaxcyte, Inc. | -1.968 |
| Caribou Biosciences, Inc. | -0.2404 |
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 80.08M |
| Revenue (Quarterly) | 238.95M |
| Total Expenses (Quarterly) | 158.87M |
| Enterprise Value | 1.538B |
| Gross Profit Margin (Quarterly) | 98.83% |
| Profit Margin (Quarterly) | 33.51% |
| Earnings Yield | -15.91% |
| Normalized Earnings Yield | -15.76 |